EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

EEDGAR/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Groups
  • Trending
  • News

More

  • Pricing
  • Community
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice. EDGAR is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. EDGAR/calls is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Pulling SEC filings + quote and writing the call…

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity
← New search
Home›Stocks›MGLD

MGLD

Marygold Companies, Inc.

Next earnings Sep 17, 2026

Last earnings -5.4% on 2026-05-12

Sell
$1.17
▼ -2.50%
$1.17▲ +48.29%
over 1Y
L $0.68H $1.30
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today-2.5%
1W+10.4%
1M+0.9%
3M+5.4%
YTD+32.5%
1Y+48.3%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Sell
Quality
C-
Valuation
Fair value
Filings
Flagged
Sell
Conviction
Horizon
Medium (3–12mo)
12-mo target
$•••

Unprofitable holding-company microcap: revenue shrinking, cash burning, its fintech growth bet paused, and a class action it can't even size.

Revenue $30.2M · FY2025

Marygold is a grab-bag holding company (USCF ETF management, New Zealand food products, Original Sprout beauty, U.S./U.K. advisory) that has swung from profitability (net income of $5.85M/$1.15M/$1.17M in FY2021–2023) to two straight years of deepening losses — a -$4.07M net loss in FY2024 widening to -$5.82M in FY2025. Revenue is going the wrong way (-8.2% to $30.2M), operating income is -$6.69M (a -22.2% operating margin despite a healthy 72.5% gross margin), and ROE is -25.3%. The 72.5% gross margin tells you the problem isn't the product economics — it's an over-built cost base spread across too many unrelated subsidiaries with no scale. Operating cash flow was -$3.32M (down 73.7%), against just $5.00M of cash, so the runway is real but finite.

The MD&A confirms the growth engine has stalled: after sinking $19.1M into its U.S. Fintech app since 2019, management paused U.S. development effective March 31, 2025, keeping only a scaled U.K. version — an admission that the single initiative meant to justify the premium has failed to gain acceptance. Working capital fell 35% (from $19.0M to $12.4M) in one year. Meanwhile USCF LLC, an indirect wholly-owned subsidiary, is the subject of class action litigation for which management explicitly states it 'unable to predict the ultimate timing or outcome of, or reasonably estimate the possible losses' — an unknowable liability sitting on a company with only $23.0M of equity.

Financials · annual, by fiscal year

Line itemFY21FY22FY23FY24FY25
Revenue———$32.8M$30.2M
Gross profit$30.6M$28.6M$26.1M$24.1M$21.9M
Operating income$7.42M$2.38M$1.42M-$6.26M-$6.69M
Net income$5.85M$1.15M$1.17M-$4.07M-$5.82M
Diluted EPS—$0.03$0.03-$0.10-$0.14
Net margin———-12.4%-19.3%

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value$45.7M
EV / EBITDA—
EV / Sales1.5
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield-11.5%
FCF yield-6.7%

Quality & risk

ROIC (est.)-23.0%
Free cash flow-$3.37M
Total debt—
Net cash$5.00M
Altman Z-Score5.23 safe
Piotroski F-Score1/8

Capital returns

Buyback yield—
Dividend yield (est.)—
Shareholder yield—
Shares Δ YoY+6.8%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Recent disclosure tone has skewed negative — read the flagged items.
  1. 8-K Earnings results2026-05-12

    Furnished Q3 FY2026 (Mar-31) earnings results; loss-making trend continues

  2. 10-Q Quarterly report2026-05-08

    Q3 FY2026: holding-company losses persist, cash burn ongoing

  3. 8-K Earnings results2026-02-10

    Furnished Q2 FY2026 (Dec-31) earnings results

  4. 10-Q Quarterly report2026-02-05

    Q2 FY2026: continued operating losses across segments

  5. 8-K Shareholder vote2025-11-10

    Furnished Q1 FY2026 (Sep-30) earnings results

  6. 8-K Earnings results2025-11-10

    Furnished Q1 FY2026 (Sep-30) earnings results

  7. 10-Q Quarterly report2025-11-07

    Q1 FY2026: first post-Brigadier-sale quarter, still unprofitable

  8. DEF 14A Proxy statement2025-09-23

    Proxy for annual meeting: director elections, auditor ratification

  9. 8-K Earnings results2025-09-22

    Furnished FY2025 results: net loss $5.8M, revenue -8%

Recent filings

all on EDGAR ↗
8-KPeriod ending 2026-05-112026-05-12open ↗10-QPeriod ending 2026-03-312026-05-08open ↗8-KPeriod ending 2026-02-052026-02-10open ↗10-QPeriod ending 2025-12-312026-02-05open ↗4Period ending 2025-12-102025-12-12open ↗4Period ending 2025-12-032025-12-04open ↗4Period ending 2025-11-202025-11-21open ↗8-KPeriod ending 2025-11-072025-11-10open ↗8-KPeriod ending 2025-11-072025-11-10open ↗4Period ending 2025-11-072025-11-10open ↗4Period ending 2025-11-072025-11-10open ↗4Period ending 2025-11-072025-11-10open ↗

Quality score

C-
ValueGrowthProfitHealthMom.
ValueA-
GrowthF
ProfitabilityF
Financial healthB-
MomentumB
  • ✗Revenue growing year-over-year
  • ✗Profitable (positive net income)
  • ✗Net margin above 10%
  • ✗Return on equity above 15%
  • ✓Liabilities below 2× equity
0.6852-week1.30
Revenue
$30.2M
-8.2% YoY
Net margin
-19.3%
ROE
-25.3%
P/E
—

SEC fundamentals · FY 2025

'21'22'23'24'25

■ revenue · ■ net income, by fiscal year

Revenue$30.2M-8.2%
Net income-$5.82M-43.0%
Gross profit$21.9M-9.3%
Operating income-$6.69M-6.9%
Diluted EPS-$0.14-40.0%
Cash & equivalents$5.00M-8.4%
Total assets$30.4M-7.5%
Total liabilities$7.43M+18.3%
Stockholders' equity$23.0M-13.6%
Gross: 72.5%Op.: -22.2%L/E: 0.32x

Frequently asked

Is Marygold Companies, Inc. (MGLD) a buy?
MGLD currently carries a Sell rating with 3/5 conviction, derived from its latest SEC filings. Unprofitable holding-company microcap: revenue shrinking, cash burning, its fintech growth bet paused, and a class action it can't even size.
What is Marygold Companies, Inc.'s quality score?
MGLD scores 50.90672043010753/100 (grade C-) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0001005101, latest 10-Q filed 2026-05-08) · EODHD · Proprietary analysis · as of 7/4/2026, 3:32:02 AM.

Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC
2025-12-10
Nicholas & Melinda Gerber Living Trust
Chief Executive Officer
Buy25.0K @ $0.93$23.2K
2025-12-03
Nicholas & Melinda Gerber Living Trust
Chief Executive Officer
Buy15.4K @ $1.03$15.7K
2025-11-20
Nicholas & Melinda Gerber Living Trust
Chief Executive Officer
Buy20.0K @ $1.05$21.0K
2025-11-07
Mullins Derek Jason
Director
Award4.85K @ $1.03$5.00K
2025-11-07
Gonzalez Matt
Director
Award4.85K @ $1.03$5.00K
2025-11-07
Alexander James S
Director
Award4.85K @ $1.03$5.00K
2025-11-07
Harris Joya
Director
Award4.85K @ $1.03$5.00K
2025-11-07
Grogan Erin
Director
Award4.85K @ $1.03$5.00K

Earnings history

beat/miss · move
2026-05-12—▼ -5.41%8-K ↗
2026-02-10—▲ +12.02%8-K ↗
2025-11-10—▼ -0.97%8-K ↗
2025-09-22—▲ +1.87%8-K ↗
2025-05-08—▲ +11.50%8-K ↗
2024-11-12—▲ 0.00%8-K ↗

Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.

Recent news

market news →
Marygold Companies GAAP EPS of -$0.01, revenue of $7M
seekingalpha.com· 2025-11-10
TER Crosses Above Key Moving Average LevelBullish
nasdaq.com· 2025-07-30
Nicholas Gerber trust buys $49,845 in Marygold Companies sharesBullish
investing.com· 2025-06-24
Marygold Companies to sell Canadian subsidiaryBullish
seekingalpha.com· 2025-06-20
The Marygold Companies Enters Agreement to Sell Canadian SubsidiaryBullish
finance.yahoo.com· 2025-06-20
11 Best Asset Management Stocks to Buy NowBullish
finance.yahoo.com· 2024-02-05

Vs tracked universe

compare →

1195 tracked peers · median

EDGAR Score51 vs 67
Revenue growth-8.2% vs 7.5%
Net margin-19.3% vs 10.0%
Return on equity-25.3% vs 12.0%
P/E— vs 26.2